The death of popular Kannada actor Puneeth Rajkumar on October 29, 2021, due to a heart attack has caused considerable concern among his admirers and the general public.

This tragedy has sparked a rise in viral social media posts and raised concerns about the safety of the COVID-19 vaccine, specifically Covishield, produced by AstraZeneca.

In addition, a tweet warning people over the age of 45 to avoid the vaccine has received a lot of attention, highlighting the growing concern over its potential negative effects.

Puneeth Rajkumar not only received the COVID-19 vaccine, but he also actively advocated for its value. He enthusiastically participated in various health department programmes aimed at educating the public on critical steps to combat the epidemic. Fans are now posting films that demonstrate his devotion to promoting immunisation.

Puneeth Rajkumar obtained his vaccination and tweeted about it on April 7, 2021, saying, “Got my first dose of vaccination today. If you are 45 years & above ensure you get vaccinated.” The message quickly gained traction among his fans, who shared it, making it go viral. However, it is unclear whether actor Puneeth Rajkumar received the Covaxin or Covishield vaccine.

Puneeth suffered chest trouble during a usual exercise on October 29, 2021, and was brought to a local clinic before being transferred to Vikram Hospital, where he died tragically.

Puneeth Rajkumar was also recognised for actively participating in public health campaigns supporting COVID-19 safety measures, such as vaccination. However, as there is a discussion regarding the negative effects of Covishield, supporters show their regret by associating it to Appu’s death.

AstraZeneca is currently facing a lawsuit in the United Kingdom on allegations that their vaccine caused deaths. 51 lawsuits have been filed against the corporation. In court documents, AstraZeneca admitted that Covishield can, in extremely rare cases, induce Thrombosis with Thrombocytopenia Syndrome (TTS).

While there is widespread scientific acceptance that vaccines are critical in controlling the development of COVID-19, concerns about Covishield have focused on thrombosis with thrombocytopenia syndrome (TTS), a disorder characterised by blood clots and low platelet levels.

However, it is worth noting that such situations are quite uncommon. Health professionals and various research have repeatedly stated that the advantages of vaccination much outweigh the hazards for the vast majority of the population.

Despite these reassurances, the unexpected spike in heart attack cases among younger populations following the epidemic has been concerning. Previously observed mostly in elderly persons, these cases have raised concerns about possible ties to the COVID-19 infection or the immunisations. As this discussion continues, public health messages must balance vaccine advocacy with open disclosure about potential hazards, no matter how remote, in order to maintain public trust.

https://twitter.com/CSDM71343778/status/1785861232727330826

Follow on Google News
TOPICS: Covishield Covishield vaccine Puneeth Rajkumar